Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to include 3 additional interventions/treatments and now lists 3 study locations, with the revision updated from v2.9.7 to v2.10.0.
    Difference
    0.4%
    Check dated 2024-07-23T14:23:32.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:23:58.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:03:12.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:47:52.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:38:16.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value on the web page has changed from 'Show more Show more Show more Revision: v2.9.0' to 'Show less Show less Genetic and Rare Diseases Information Center resources: Glioblastoma Gliosarcoma Glioma Neuroepithelioma Drug Information available for: Temozolomide Pembrolizumab FDA Drug and Device Resources Show less'. This change represents an update in the displayed information regarding genetic and rare diseases resources related to glioblastoma, gliosarcoma, glioma, and neuroepithelioma, as well as drug information available for Temozolomide and Pembrolizumab.
    Difference
    44%
    Check dated 2024-06-25T08:16:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.